Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

Condition:   Asthma; Eosinophilic Intervention:   Biological: Mepolizumab given SC 100mg every 4 weeks between Dec 2017 and Dec 2019 Sponsors:   Medical University of Lodz;   GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials